Unaudited Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income (loss)	$ 1,114,193	$ (303,070)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
General and administrative expenses paid by Sponsor through note payable		24,589
Change in fair value of derivative warrant liabilities	(1,546,370)	(184,000)
Financing cost - derivative warrant liabilities		314,650
Gain on investments held in Trust Account	(28,731)	(3,736)
Changes in operating assets and liabilities:
Prepaid expenses	95,125	(161,093)
Accounts payable	75,541	41,708
Franchise tax payable	99,726	119,452
Accrued expenses	(14,000)	(1,000)
Net cash used in operating activities	(204,516)	(152,500)
Cash Flows from Investing Activities
Cash deposited in Trust Account		(116,725,000)
Net cash used in investing activities		(116,725,000)
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross		115,000,000
Proceeds received from private placement		5,525,000
Offering costs paid		(2,535,500)
Net cash provided by financing activities		117,989,500
Net (decrease) increase in cash	(204,516)	1,112,000
Cash - beginning of the period	707,837
Cash - end of the period	503,321	1,112,000
Supplemental disclosure of noncash activities:
Offering costs included in accounts payable		37,278
Offering costs included in accrued expenses		86,300
Offering costs paid through note payable to Sponsor		77,370
Deferred underwriting commissions in connection with the initial public offering		$ 4,025,000